What Researchers Did
Researchers studied 67 patients with tuberculous empyema and bronchial fistulas after lung surgery, using hyperbaric oxygen therapy as part of their overall treatment.
What They Found
The study found that 33.8% (23 patients) experienced closure of their bronchial fistula, while 24.5% (16 patients) saw a decrease in fistula diameter. However, 41.7% of patients did not achieve fistula closure. Additionally, patients showed changes in blood cell counts and inflammatory markers, including increased red blood cell production, decreased white blood cell counts, and lower levels of certain immune complexes.
What This Means for Canadian Patients
For Canadian patients facing the serious complication of tuberculous empyema and bronchial fistulas after lung surgery, this study suggests that hyperbaric oxygen therapy could be a beneficial part of their comprehensive treatment plan. HBOT might help promote the healing of fistulas and reduce inflammation, potentially improving recovery outcomes for this challenging condition.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study is limited by its age (published in 1989) and the lack of a control group, making it difficult to definitively assess the specific impact of hyperbaric oxygen therapy alone.